<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03078764</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00118973</org_study_id>
    <secondary_id>5D43TW009883-03</secondary_id>
    <nct_id>NCT03078764</nct_id>
  </id_info>
  <brief_title>The Adaptation, Usability, and Feasibility of a Mobile Health (mHealth) System to Improve Type 2 Diabetes Self-management in Thailand</brief_title>
  <official_title>The Adaptation, Usability, and Feasibility of a Mobile Health (mHealth) System to Improve Type 2 Diabetes Self-management in Thailand</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>John E. Fogarty International Center (FIC)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project explores the feasibility of using automated telephone calls to adult patients
      with type 2 diabetes to improve diabetes self-management in Thailand. This line of work could
      significantly extend Thai nurses' ability to manage this growing epidemic, and ultimately
      reduce the suffering and costs caused by diabetes in Thailand.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is a serious shortage of community nurses to address Thailand's significant and
      expanding burden of poorly controlled type 2 diabetes. However, mobile health (mHealth)
      strategies are likely to significantly improve and extend Thai nurses' ability to monitor and
      manage these patients. This study aims to:

      1) investigate the feasibility and acceptability of a culturally- and clinically-adapted
      mHealth intervention with adult Thai diabetic patients and their community nurses, and 2)
      estimate the intervention's effect upon glycated hemoglobin (HbA1c), fasting blood glucose,
      self-management behaviors, and diabetes-related distress in uncontrolled type 2 diabetes.
      Thirty-six patients with poorly controlled type 2 diabetes (along with their regular nurses)
      will be recruited through an established community clinic network. After baseline clinical
      and behavioral assessment, patients will receive 12 weeks of automated 10-minute weekly
      Interactive Voice Response (IVR) calls to provide monitoring and self-management support
      related to glycemic symptoms, medication adherence, and several self-care behaviors.
      Patients' clinical nurse will receive weekly summaries of each IVR call by text message and
      email with guidance on Thai-appropriate best practices. Principal investigator will receive
      email whenever patients report a potentially urgent issue by IVR, i.e., symptoms of
      hypoglycemia, or inadequate supply of medication. Immediately after the 12-week intervention
      concludes, clinical and behavioral variables will be reassessed and a mixed-methods process
      evaluation will be performed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 9, 2017</start_date>
  <completion_date type="Actual">December 1, 2017</completion_date>
  <primary_completion_date type="Actual">December 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HbA1c</measure>
    <time_frame>13 weeks</time_frame>
    <description>It refers to glycated haemoglobin, which identifies average plasma glucose concentration.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diabetes related distress</measure>
    <time_frame>13 weeks</time_frame>
    <description>It will be measured using the emotional and regimen subscales of a Thai translation of the well-validated Diabetes Distress Scale. This is a reliable and validated scale, and correlates with other measures of emotional distress. The responses range from 1-6. The higher scores indicate a greater degree of distress.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fasting blood glucose</measure>
    <time_frame>13 weeks</time_frame>
    <description>It refers to blood glucose levels after refraining eating or drinking for at least 8 hours.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Sleep quality</measure>
    <time_frame>13 weeks</time_frame>
    <description>It will be assessed using the same single item used during the IVR assessment, along with the PROMIS Sleep Disturbance-Short Form. The PROMIS (Patient-Report Outcomes Information System) Sleep Disturbance-Short Form is a 4-item self-report instrument covering the quality of sleep-wake functioning. Responses are scored on a 5-point Likert scale. The higher scores indicating a greater degree of sleep disturbance.</description>
  </other_outcome>
  <other_outcome>
    <measure>Dietary consumption</measure>
    <time_frame>13 weeks</time_frame>
    <description>It will be assessed using the same single item used during the IVR assessment. The responses range from 0 to 7 (days).</description>
  </other_outcome>
  <other_outcome>
    <measure>Physical activity</measure>
    <time_frame>13 weeks</time_frame>
    <description>It will be assessed using the Stanford Leisure-Time Activity Categorical Item (Kiernan et al., 2013), which consists of 6 descriptive categories ranging from inactive (1) to very active, almost daily physical activity (6).</description>
  </other_outcome>
  <other_outcome>
    <measure>Foot care</measure>
    <time_frame>13 weeks</time_frame>
    <description>It will be assessed using the same single item used during the IVR assessment. The responses range from 0 to 7 (days).</description>
  </other_outcome>
  <other_outcome>
    <measure>Symptoms of hypoglycemia</measure>
    <time_frame>13 weeks</time_frame>
    <description>It will be assessed using a 7 items that ask about low blood sugar symptoms, the same that the study team describe in the IVR calls. The responses range from 0 (not at all) to 4 (6-7 days a week). The higher scores indicate a greater degree of hypoglycemic symptoms.</description>
  </other_outcome>
  <other_outcome>
    <measure>Depressive symptoms severity</measure>
    <time_frame>13 weeks</time_frame>
    <description>It will be assessed using the Patient Health Questionnaire-8 (PHQ-8) (Kroenke et al., 2009). It consists of 8 items with a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day). Higher scores indicate greater depressive symptom severity.</description>
  </other_outcome>
  <other_outcome>
    <measure>Readiness for change</measure>
    <time_frame>13 weeks</time_frame>
    <description>It will be assessed using 5 items from our prior research that is specifically worded to measure participants'preparedness to change the 5 diabetes self-care behaviors that our program targets, which are answered using a 7-point Likert scale ranging from 1 (not at all) to 7 (very much so). Higher scores indicate greater readiness for change.</description>
  </other_outcome>
  <other_outcome>
    <measure>Diabetes self-efficacy</measure>
    <time_frame>13 weeks</time_frame>
    <description>It will be assessed with the Self-Efficacy for Diabetes Scale (Ritter et al., 2016). The scale consists of 8 items with 10- point Likert scale ranging from 1 (not at all confident) to 10 (totally confident). Higher scores indicate greater self-efficacy.</description>
  </other_outcome>
  <other_outcome>
    <measure>Medical adherence</measure>
    <time_frame>13 weeks</time_frame>
    <description>It will be assessed using the Hill-Bone Compliance Scale (Kim et al., 2000), assesses how often patients miss taking medications, rated on a 4-point Likert scale ranging from 1(none of the time) to 4 (all of the time). In the study, only 8 items of Hill-Bone Compliance scale will be used. Reverse coded before analysis will be performed. Higher scores indicate greater medication adherence. In addition, 1-item of the Brief Medication Questionnaire will be used, which allows calculation of percent adherence over the past 2 weeks</description>
  </other_outcome>
  <other_outcome>
    <measure>Social support</measure>
    <time_frame>13 weeks</time_frame>
    <description>It will be assessed using selected items from the Norbeck Social Support Questionnaire, which is a validated measure of number, type, and quality of relationships (Norbeck, 1983). For the purpose of this study, the 6 items (item 3-8) will be scored on a 5-point Likert scale ranging from 0 (not at all) to 4 (a great deal). Higher scores indicate better social support.</description>
  </other_outcome>
  <other_outcome>
    <measure>Health literacy</measure>
    <time_frame>13 weeks</time_frame>
    <description>It will be assessed using the 3-item screener developed by Chew et al. for detecting probable inadequate health literacy (45, 46). Higher scores indicate better health literacy.</description>
  </other_outcome>
  <other_outcome>
    <measure>Client satisfaction</measure>
    <time_frame>13 weeks</time_frame>
    <description>will be measured using the Client Satisfaction Questionnaire (CSQ-8) (Attkisson, Zwick, 1982), which assesses satisfaction with specific providers, settings, and time intervals, along with open-ended items (within the exit interview) adapted from prior mHealth research studies. Higher scores indicate greater satisfaction of the program.</description>
  </other_outcome>
  <other_outcome>
    <measure>Self-efficacy (for nurse)</measure>
    <time_frame>13 weeks</time_frame>
    <description>It will be measured using Nurse Self-efficacy for Diabetes Care using 11 items developed for this study that correspond to patients' IVR content areas.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Patient Arm using mHealth</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with uncontrolled type 2 diabetes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Community nurses</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nurses who receive mHealth report about patients in the patients' arm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mobile health system</intervention_name>
    <description>Patients will receive weekly automated IVR telephone calls for 12 weeks to assess their glycemic symptoms, medication adherence, dietary consumption, physical activity, sleep, and foot care. These 5-10 minute calls will follow a standardized Thai language IVR script developed specifically for this study.</description>
    <arm_group_label>Patient Arm using mHealth</arm_group_label>
    <other_name>mHealth</other_name>
    <other_name>Interactive Voice Response (IVR)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>E-mail reports and technical support for mHealth system</intervention_name>
    <description>Nurses will also receive a technical troubleshooting guide, and have similar access to live telephone technical support. Once their patients' calls begin, nurses will begin receiving weekly e-mail reports summarizing each patients' assessment results, any active self-management problems the patients reported, and suggested strategies for supporting the patient's self-management.</description>
    <arm_group_label>Community nurses</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        For patients:

          1. poorly controlled type 2 diabetes as indicated by HbA1c â‰¥ 7.5% recorded within past 6
             months

          2. aged 20 years and older

          3. currently being treated by oral antihyperglycemic

          4. communicates and reads in Thai

          5. has access to and able to use a touch-tone phone (either a land line or a mobile
             phone)

          6. free of major physical, cognitive, or psychiatric impairment (per medical records and
             PI discretion) that would prevent them from participating meaningfully in the
             intervention.

        Inclusion criteria:

        For nurses:

          1. works in a non-communicable disease clinic.

          2. can access email

          3. has a mobile telephone.

        Exclusion Criteria:

        For patients:

          1. have participated in other mHealth interventions within 3 months

          2. have baseline HbA1c &lt; 7.5%

          3. are hospitalized or otherwise at risk for hospitalization

          4. are prescribed injected insulin

          5. patients and nurses who participated in the usability trial will be ineligible to
             participate in the pilot trial.

        Exclusion criteria:

        For nurses: None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Panan Pichayapinyo, PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Buengbon Health Promoting Hospital</name>
      <address>
        <city>Nong Sua</city>
        <state>Pathumthani</state>
        <zip>12170</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Buengkasam 1 Health Promoting Hospital</name>
      <address>
        <city>Nong Sua</city>
        <state>Pathumthani</state>
        <zip>12170</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Buengkasam 2 Health Promoting Hospital</name>
      <address>
        <city>Nong Sua</city>
        <state>Pathumthani</state>
        <zip>12170</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Buengshamaor 1 Health Promoting Hospital</name>
      <address>
        <city>Nong Sua</city>
        <state>Pathumthani</state>
        <zip>12170</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nongsamwang 1 Health Promoting Hospital</name>
      <address>
        <city>Nong Sua</city>
        <state>Pathumthani</state>
        <zip>12170</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Salakru Health Promoting Hospital</name>
      <address>
        <city>Nong Sua</city>
        <state>Pathumthani</state>
        <zip>12170</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2017</study_first_submitted>
  <study_first_submitted_qc>March 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 13, 2017</study_first_posted>
  <last_update_submitted>December 20, 2017</last_update_submitted>
  <last_update_submitted_qc>December 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Panan Pichayapinyo</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Mobile health (mHealth)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

